Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Jul 23.
doi: 10.1007/s40273-025-01522-y. Online ahead of print.

Cost Comparisons in NICE Technology Appraisals: An External Assessment Group Perspective

Marten J Poley  1 , Nigel Armstrong  2 , Huiqin Yang  2 , Mubarak Patel  2 , Lisa Stirk  2 , Maiwenn J Al  3 , Isaac Corro Ramos  4
Affiliations
Editorial

Cost Comparisons in NICE Technology Appraisals: An External Assessment Group Perspective

Marten J Poley et al. Pharmacoeconomics. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declarations. Funding: The EAG report leading to this work was commissioned by the National Institute for Health Research (NIHR) Evidence Synthesis Programme as project number NIHR165359. See the health technology assessment programme website for further project information: https://www.nihr.ac.uk/research-funding/funding-programmes/health-technology-assessment . This summary was compiled after NICE issued the Final Appraisal Determination. The views and opinions expressed herein represent those of the authors and do not necessarily reflect those of NICE or the Department of Health. Conflict of interest: The authors declare no conflicts of interest in relation to this work. ICR is an Editorial Board Member of PharmacoEconomics. He was not involved in the selection of peer reviewers for the manuscript, nor any of the subsequent editorial decisions. Ethics approval: Not applicable. Informed consent: Not applicable. Data availability: Not applicable. Consent to participate: Not applicable. Consent for publication: Not applicable. Code availability: Not applicable. Author contributions: All authors contributed to the manuscript conception and design and were involved with the work of the EAG.

Similar articles

See all similar articles

References

    1. National Institute for Health and Care Excellence. NICE health technology evaluations: the manual. NICE process and methods [PMG36] [Internet]. London: National Institute for Health and Care Excellence; 2023. p. 200. https://www.nice.org.uk/process/pmg36/resources/nice-health-technology-e... . Accessed 10.1.24.
    1. National Institute for Health and Care Excellence. NICE health technology evaluations: the manual. NICE process and methods [PMG36]. Update information [Internet]. London: National Institute for Health and Care Excellence; 2025. https://www.nice.org.uk/process/pmg36/chapter/update-information . Accessed 9.4.25.
    1. National Institute for Health and Care Excellence. Faricimab for treating visual impairment caused by macular oedema after retinal vein occlusion [TA1004] [Internet]. London: NICE; 2024. https://www.nice.org.uk/guidance/ta1004 . Accessed 13.5.25.
    1. National Institute for Health and Care Excellence. Crovalimab for treating paroxysmal nocturnal haemoglobinuria in people 12 years and over [TA1019] [Internet]. London: NICE; 2024. https://www.nice.org.uk/guidance/ta1019 . Accessed 13.5.25.
    1. American Academy of Ophthalmology. Retinal Vein Occlusions Preferred Practice Pattern(R). American Academy of Ophthalmology; 2019. p. 33. https://www.aao.org/education/preferred-practice-pattern/retinal-vein-oc... . Accessed 12.2.24.

Publication types

LinkOut - more resources